Abstract Overview: Randomized Phase II Trial for Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (mPDA) - 102164

Spotlight
Video

Abstract Overview: Randomized Phase II Trial for Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (mPDA)

Loading........
Description: William P. Harris, MD of Seattle Cancer Care Alliance discusses metastatic pancreatic cancer for the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract 4008: Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA).
Shared By : AnnualMeeting2017
Posted on : 06/06/17
Added : 1 year ago
Category : Pancreatic Cancer